638 research outputs found
A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses
Background. Glioblastoma (GBM) is the most common primary brain tumor, with dismal prognosis. The failure of drug–radiation
combinations with promising preclinical data to translate into effective clinical treatments may relate to the use of simplified
2-dimensional in vitro GBM cultures.
Methods. We developed a customized 3D GBM culture system based on a polystyrene scaffold (Alvetex) that recapitulates key
histological features of GBM and compared it with conventional 2D cultures with respect to their response to radiation and to
molecular targeted agents for which clinical data are available.
Results. In 3 patient-derived GBM lines, no difference in radiation sensitivity was observed between 2D and 3D cultures, as
measured by clonogenic survival. Three different molecular targeted agents, for which robust clinical data are available were
evaluated in 2D and 3D conditions: (i) temozolomide, which improves overall survival and is standard of care for GBM, exhibited
statistically significant effects on clonogenic survival in both patient-derived cell lines when evaluated in the 3D model compared
with only one cell line in 2D cells; (ii) bevacizumab, which has been shown to increase progression-free survival when added to
standard chemoradiation in phase III clinical trials, exhibited marked radiosensitizing activity in our 3D model but had no effect
on 2D cells; and (iii) erlotinib, which had no efficacy in clinical trials, displayed no activity in our 3D GBM model, but radiosensitized
2D cells.
Conclusions. Our 3D model reliably predicted clinical efficacy, strongly supporting its clinical relevance and potential value in
preclinical evaluation of drug–radiation combinations for GBM
Human Research Ethics Committee Experiences and Views About Children's Participation in Research: Results From the MESSI Study.
As part of a larger study, Australian Human Research Ethics Committee (HREC) members and managers were surveyed about their decision-making and views about social research studies with child participants. Responses of 229 HREC members and 42 HREC managers are reported. While most HREC members had received ethical training, HREC training and guidelines specific to research involving children were rare. Most applications involving children had to go through a full ethical review, but few adverse events were reported to HRECs regarding the conduct of the studies. Revisions to study proposals requested by HRECs were mostly related to consent processes and age-appropriate language. One-third of HREC members said that they would approve research on any topic. Most were also concerned that the methodology was appropriate, and the risks and benefits were clearly articulated. Specific training and guidance are needed to increase HREC members' confidence to judge ethical research with children
Children and young people’s decision-making in social research about sensitive issues
Limited attention has been given to what motivates and informs children and young people’s decision to participate (or not) in social research, especially about sensitive issues. This paper reports the findings from focus group interviews with children and young people aged 9–16 years, undertaken as part of a larger study that explored what constitutes a sensitive issue in social research and the factors considered when deciding to participate. Participants articulated a range of intrinsic and extrinsic motivations: benefiting others, getting something out of it, getting things ‘off your chest’ and the role of incentives and trusted adults. While similar to findings about medical research, the data from this study provides deeper insight into how children and young people make decisions to participate in social research. The critical role that accessible information plays in supporting children’s considered decision-making is highlighted, along with rich insights into why research might matter for themselves and others
Food-Level Analysis to Identify Dietary Choices With the Highest Nutritional Quality and Lowest Greenhouse Gas Emissions and Price
FUNDING This research was funded by the Scottish Government’s Rural and Environment Science and Analytical Services Division (RESAS) and responsive opportunity funding from the Scottish Environment, Food and Agriculture Research Institutes (SEFARI).Peer reviewedPublisher PD
Nutritional Quality, Environmental Impact and Cost of Ultra-Processed Foods : A UK Food-Based Analysis
This research was funded by the Scottish Government’s Rural and Environment Science and Analytical Services Division (RESAS) and responsive opportunity funding from the Scottish Environment, Food and Agriculture Research Institutes (SEFARI).Peer reviewedPublisher PD
Increasing value and reducing waste in biomedical research: who's listening?
The biomedical research complex has been estimated to consume almost a quarter of a trillion US dollars every year. Unfortunately, evidence suggests that a high proportion of this sum is avoidably wasted. In 2014, The Lancet published a series of five reviews showing how dividends from the investment in research might be increased from the relevance and priorities of the questions being asked, to how the research is designed, conducted, and reported. 17 recommendations were addressed to five main stakeholders-funders, regulators, journals, academic institutions, and researchers. This Review provides some initial observations on the possible effects of the Series, which seems to have provoked several important discussions and is on the agendas of several key players. Some examples of individual initiatives show ways to reduce waste and increase value in biomedical research. This momentum will probably move strongly across stakeholder groups, if collaborative relationships evolve between key players; further important work is needed to increase research value. A forthcoming meeting in Edinburgh, UK, will provide an initial forum within which to foster the collaboration neede
Consciousness is Underived Intentionality
Representationalists argue that phenomenal states are intentional states of a special kind. This paper offers an account of the kind of intentional state phenomenal states are: I argue that they are underived intentional states. This account of phenomenal states is equivalent to two theses: first, all possible phenomenal states are underived intentional states; second, all possible underived intentional states are phenomenal states. I clarify these claims and argue for each of them. I also address objections which touch on a range of topics, including meaning holism and concept empiricism. I conclude with a brief discussion of the consequences of the proposed view for the project of naturalizing consciousness
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study
<p>Background: Randomized controlled trials have shown the importance of tight glucose control in type 1 diabetes (T1DM), but few recent studies have evaluated the risk of cardiovascular disease (CVD) and all-cause mortality among adults with T1DM. We evaluated these risks in adults with T1DM compared with the non-diabetic population in a nationwide study from Scotland and examined control of CVD risk factors in those with T1DM.</p>
<p>Methods and Findings: The Scottish Care Information-Diabetes Collaboration database was used to identify all people registered with T1DM and aged ≥20 years in 2005–2007 and to provide risk factor data. Major CVD events and deaths were obtained from the national hospital admissions database and death register. The age-adjusted incidence rate ratio (IRR) for CVD and mortality in T1DM (n = 21,789) versus the non-diabetic population (3.96 million) was estimated using Poisson regression. The age-adjusted IRR for first CVD event associated with T1DM versus the non-diabetic population was higher in women (3.0: 95% CI 2.4–3.8, p<0.001) than men (2.3: 2.0–2.7, p<0.001) while the IRR for all-cause mortality associated with T1DM was comparable at 2.6 (2.2–3.0, p<0.001) in men and 2.7 (2.2–3.4, p<0.001) in women. Between 2005–2007, among individuals with T1DM, 34 of 123 deaths among 10,173 who were <40 years and 37 of 907 deaths among 12,739 who were ≥40 years had an underlying cause of death of coma or diabetic ketoacidosis. Among individuals 60–69 years, approximately three extra deaths per 100 per year occurred among men with T1DM (28.51/1,000 person years at risk), and two per 100 per year for women (17.99/1,000 person years at risk). 28% of those with T1DM were current smokers, 13% achieved target HbA1c of <7% and 37% had very poor (≥9%) glycaemic control. Among those aged ≥40, 37% had blood pressures above even conservative targets (≥140/90 mmHg) and 39% of those ≥40 years were not on a statin. Although many of these risk factors were comparable to those previously reported in other developed countries, CVD and mortality rates may not be generalizable to other countries. Limitations included lack of information on the specific insulin therapy used.</p>
<p>Conclusions: Although the relative risks for CVD and total mortality associated with T1DM in this population have declined relative to earlier studies, T1DM continues to be associated with higher CVD and death rates than the non-diabetic population. Risk factor management should be improved to further reduce risk but better treatment approaches for achieving good glycaemic control are badly needed.</p>
BPS saturation of the N=4 monopole by infinite composite-operator renormalization
Quantum corrections to the magnetic central charge of the monopole in N=4
supersymmetric Yang-Mills theory are free from the anomalous contributions that
were crucial for BPS saturation of the two-dimensional supersymmetric kink and
the N=2 monopole. However these quantum corrections are nontrivial and they
require infinite renormalization of the supersymmetry current, central charges,
and energy-momentum tensor, in contrast to N=2 and even though the N=4 theory
is finite. Their composite-operator renormalization leads to counterterms which
form a multiplet of improvement terms. Using on-shell renormalization
conditions the quantum corrections to the mass and the central charge then
vanish both, thus verifying quantum BPS saturation.Comment: 1+14 pages, 2 figures. v3: version to appear in Phys. Lett. B (Note
added and minor corrections
the relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes
OBJECTIVE Moderate alcohol consumption has been associated with a reduced risk of mortality and coronary artery disease. The relationship between cardiovascular health and alcohol use in type 2 diabetes is less clear. The current study assesses the effects of alcohol use among participants in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. RESEARCH DESIGN AND METHODS The effects of alcohol use were explored using Cox regression models, adjusted for potential confounders. The study end points were cardiovascular events (cardiovascular death, myocardial infarction, and stroke), microvascular complications (new or worsening nephropathy or retinopathy), and all-cause mortality. RESULTS During a median of 5 years of follow-up, 1,031 (9%) patients died, 1,147 (10%) experienced a cardiovascular event, and 1,136 (10%) experienced a microvascular complication. Compared with patients who reported no alcohol consumption, those who reported moderate consumption had fewer cardiovascular events (adjusted hazard ratio [aHR] 0.83; 95% CI 0.72–0.95; P = 0.008), less microvascular complications (aHR 0.85; 95% CI 0.73–0.99; P = 0.03), and lower all-cause mortality (aHR 0.87; 96% CI 0.75–1.00; P = 0.05). The benefits were particularly evident in participants who drank predominantly wine (cardiovascular events aHR 0.78, 95% CI 0.63–0.95, P = 0.01; all-cause mortality aHR 0.77, 95% CI 0.62–0.95, P = 0.02). Compared with patients who reported no alcohol consumption, those who reported heavy consumption had dose-dependent higher risks of cardiovascular events and all-cause mortality. CONCLUSION In patients with type 2 diabetes, moderate alcohol use, particularly wine consumption, is associated with reduced risks of cardiovascular events and all-cause mortality
- …